Published in AIDS on March 27, 2013
Virulence and pathogenesis of HIV-1 infection: an evolutionary perspective. Science (2014) 1.46
Understanding HIV epidemics: aggregate viral load metrics and 'smoking guns'. AIDS (2013) 1.39
Mapping HIV clustering: a strategy for identifying populations at high risk of HIV infection in sub-Saharan Africa. Int J Health Geogr (2013) 1.27
Sources of HIV incidence among stable couples in sub-Saharan Africa. J Int AIDS Soc (2014) 1.18
Have the explosive HIV epidemics in Sub-Saharan Africa been driven by higher community viral load? AIDS (2013) 1.08
Have the explosive HIV epidemics in sub-Saharan Africa been driven by higher community viral load? AIDS (2013) 0.78
What explains gender inequalities in HIV/AIDS prevalence in sub-Saharan Africa? Evidence from the demographic and health surveys. BMC Public Health (2016) 0.77
How does population viral load vary with the evolution of a large HIV epidemic in sub-Saharan Africa? AIDS (2014) 0.75
Expanding the prevention armamentarium portfolio: a framework for promoting HIV-Conversant Communities within a complex, adaptive epidemiological landscape. SAHARA J (2015) 0.75
The HIV-1 transmission bottleneck. Retrovirology (2017) 0.75
Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med (2011) 69.36
Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med (2000) 41.18
The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature (2005) 31.73
Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet (2010) 16.90
Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet (2001) 13.32
Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One (2010) 10.39
Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis (2009) 6.96
Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa. AIDS Res Hum Retroviruses (2001) 6.00
Dual infection with HIV and malaria fuels the spread of both diseases in sub-Saharan Africa. Science (2006) 4.35
Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults. J Infect Dis (2008) 4.05
Extended high viremics: a substantial fraction of individuals maintain high plasma viral RNA levels after acute HIV-1 subtype C infection. AIDS (2011) 3.95
Evaluation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from Kenya. J Clin Microbiol (2000) 3.83
Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study. Lancet (2005) 3.48
High levels of human immunodeficiency virus type 1 in blood and semen of seropositive men in sub-Saharan Africa. J Infect Dis (1998) 3.46
Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa. PLoS One (2008) 3.05
HIV-malaria co-infection: effects of malaria on the prevalence of HIV in East sub-Saharan Africa. Int J Epidemiol (2011) 2.66
Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk. PLoS One (2010) 2.48
Progression to symptomatic disease in people infected with HIV-1 in rural Uganda: prospective cohort study. BMJ (2002) 2.31
Treatment of sexually transmitted infections for HIV prevention: end of the road or new beginning? AIDS (2010) 2.17
A tale of two countries: rethinking sexual risk for HIV among young people in South Africa and the United States. J Adolesc Health (2011) 2.00
A LONGITUDINAL SURVEY OF NATURAL MALARIA INFECTION IN A GROUP OF WEST AFRICAN ADULTS. West Afr Med J (1963) 1.95
Amplified HIV transmission and new approaches to HIV prevention. J Infect Dis (2005) 1.95
Sexual networks and HIV. AIDS (1997) 1.92
The natural history of HIV-1 and HIV-2 infections in adults in Africa: a literature review. Bull World Health Organ (2004) 1.76
Plasmodium falciparum clinical malaria in Dielmo, a holoendemic area in Senegal: no influence of acquired immunity on initial symptomatology and severity of malaria attacks. Am J Trop Med Hyg (1999) 1.61
Increased levels of immune activation in the genital tract of healthy young women from sub-Saharan Africa. AIDS (2010) 1.47
Immunological activation markers in the serum of African and European HIV-seropositive and seronegative individuals. AIDS (1996) 1.39
The role of coinfections in HIV epidemic trajectory and positive prevention: a systematic review and meta-analysis. AIDS (2011) 1.38
Viral load levels measured at set-point have risen over the last decade of the HIV epidemic in the Netherlands. PLoS One (2009) 1.20
Biological factors that may contribute to regional and racial disparities in HIV prevalence. Am J Reprod Immunol (2011) 1.15
African descent is associated with slower CD4 cell count decline in treatment-naive patients of the Swiss HIV Cohort Study. AIDS (2009) 1.08
Increased CCR5 expression with decreased beta chemokine secretion in Ethiopians: relevance to AIDS in Africa. J Hum Virol (1999) 1.07
Time to refocus on HSV interventions for HIV prevention? J Infect Dis (2011) 0.88
Mitigation strategies for pandemic influenza in the United States. Proc Natl Acad Sci U S A (2006) 17.88
Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N Engl J Med (2012) 12.98
Towards a common definition of global health. Lancet (2009) 12.36
Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol (2004) 12.03
Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS (2006) 10.56
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis. Lancet (2008) 8.37
Modeling targeted layered containment of an influenza pandemic in the United States. Proc Natl Acad Sci U S A (2008) 8.27
Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. N Engl J Med (2007) 7.79
Containing bioterrorist smallpox. Science (2002) 7.62
Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med (2008) 7.49
Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design. J Natl Cancer Inst (2008) 6.79
The transmissibility and control of pandemic influenza A (H1N1) virus. Science (2009) 6.53
Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies. J Virol (2009) 5.91
Medicine. The need for a global HIV vaccine enterprise. Science (2003) 4.70
Dual infection with HIV and malaria fuels the spread of both diseases in sub-Saharan Africa. Science (2006) 4.35
Weighing the gold in the gold standard: challenges in HIV prevention research. AIDS (2010) 4.20
Male circumcision for HIV prevention: from evidence to action? AIDS (2008) 4.11
Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study. Lancet Infect Dis (2011) 3.71
Biological and behavioural impact of an adolescent sexual health intervention in Tanzania: a community-randomized trial. AIDS (2007) 3.51
Antiviral effects on influenza viral transmission and pathogenicity: observations from household-based trials. Am J Epidemiol (2006) 3.48
A 4-year study of the epidemiology of Vibrio cholerae in four rural areas of Bangladesh. J Infect Dis (2002) 3.27
Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine. N Engl J Med (2013) 3.24
Critical factors influencing the occurrence of Vibrio cholerae in the environment of Bangladesh. Appl Environ Microbiol (2005) 3.17
Evaluation of a community-based rehabilitation model for chronic schizophrenia in rural India. Br J Psychiatry (2003) 3.15
Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa. PLoS One (2008) 3.05
Design and Evaluation of Prophylactic Interventions Using Infectious Disease Incidence Data from Close Contact Groups. J R Stat Soc Ser C Appl Stat (2006) 2.97
Insights into latent class analysis of diagnostic test performance. Biostatistics (2006) 2.92
The emerging threat of untreatable gonococcal infection. N Engl J Med (2012) 2.85
Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics. Proc Natl Acad Sci U S A (2009) 2.78
Combination HIV prevention: significance, challenges, and opportunities. Curr HIV/AIDS Rep (2011) 2.72
Creating and validating an algorithm to measure AIDS mortality in the adult population using verbal autopsy. PLoS Med (2006) 2.70
Population-wide benefits of routine vaccination of children against influenza. Vaccine (2005) 2.68
Net reclassification indices for evaluating risk prediction instruments: a critical review. Epidemiology (2014) 2.67
Performance of commercially available enzyme immunoassays for detection of antibodies against herpes simplex virus type 2 in African populations. J Clin Microbiol (2004) 2.55
Male circumcision for HIV prevention in sub-Saharan Africa: who, what and when? AIDS (2008) 2.54
School opening dates predict pandemic influenza A(H1N1) outbreaks in the United States. J Infect Dis (2010) 2.54
Detecting human-to-human transmission of avian influenza A (H5N1). Emerg Infect Dis (2007) 2.53
Estimating efficacy of trivalent, cold-adapted, influenza virus vaccine (CAIV-T) against influenza A (H1N1) and B using surveillance cultures. Am J Epidemiol (2003) 2.50
Strategies for pandemic and seasonal influenza vaccination of schoolchildren in the United States. Am J Epidemiol (2009) 2.47
FluTE, a publicly available stochastic influenza epidemic simulation model. PLoS Comput Biol (2010) 2.41
Economic evaluation of influenza pandemic mitigation strategies in the United States using a stochastic microsimulation transmission model. Value Health (2008) 2.31
Fine particulate matter and mortality: a comparison of the six cities and American Cancer Society cohorts with a medicare cohort. Epidemiology (2008) 2.25
Hand, foot, and mouth disease in China: patterns of spread and transmissibility. Epidemiology (2011) 2.13
Vaccination strategies for epidemic cholera in Haiti with implications for the developing world. Proc Natl Acad Sci U S A (2011) 2.10
Long-term biological and behavioural impact of an adolescent sexual health intervention in Tanzania: follow-up survey of the community-based MEMA kwa Vijana Trial. PLoS Med (2010) 2.09
Estimating influenza vaccine efficacy from challenge and community-based study data. Am J Epidemiol (2008) 2.07
Estimation and Comparison of Receiver Operating Characteristic Curves. Stata J (2009) 2.07
No HIV stage is dominant in driving the HIV epidemic in sub-Saharan Africa. AIDS (2008) 2.04
Public health. Community studies for vaccinating schoolchildren against influenza. Science (2006) 2.04
Herpes simplex virus type 2: a key role in HIV incidence. AIDS (2009) 2.03
High HIV testing uptake and linkage to care in a novel program of home-based HIV counseling and testing with facilitated referral in KwaZulu-Natal, South Africa. J Acquir Immune Defic Syndr (2013) 1.97
Finding optimal vaccination strategies for pandemic influenza using genetic algorithms. J Theor Biol (2005) 1.88
Effects of HIV-1 serostatus, HIV-1 RNA concentration, and CD4 cell count on the incidence of malaria infection in a cohort of adults in rural Malawi. J Infect Dis (2005) 1.88
Net risk reclassification p values: valid or misleading? J Natl Cancer Inst (2014) 1.86
Preclinical assessment of HIV vaccines and microbicides by repeated low-dose virus challenges. PLoS Med (2005) 1.85
Studies needed to address public health challenges of the 2009 H1N1 influenza pandemic: insights from modeling. PLoS Med (2010) 1.83
Community interventions and the epidemic prevention potential. Vaccine (2002) 1.82
HIV vaccines: new frontiers in vaccine development. Clin Infect Dis (2006) 1.82
Adverse birth outcomes in United Republic of Tanzania--impact and prevention of maternal risk factors. Bull World Health Organ (2007) 1.78
Serum IgG3 to the Plasmodium falciparum merozoite surface protein 2 is strongly associated with a reduced prospective risk of malaria. Parasite Immunol (2003) 1.77
Cost-effectiveness of community-based strategies to strengthen the continuum of HIV care in rural South Africa: a health economic modelling analysis. Lancet HIV (2015) 1.77
Cephalosporin-resistant gonorrhea in North America. JAMA (2013) 1.76
Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine. J Clin Invest (2011) 1.73
Letter by Pepe et al regarding article, "Use and misuse of the receiver operating characteristic curve in risk prediction". Circulation (2007) 1.71
Persisting with prevention: the importance of adherence for HIV prevention. Emerg Themes Epidemiol (2008) 1.71
Risk factors for herpes simplex virus type 2 and HIV among women at high risk in northwestern Tanzania: preparing for an HSV-2 intervention trial. J Acquir Immune Defic Syndr (2007) 1.69
What is the best control strategy for multiple infectious disease outbreaks? Proc Biol Sci (2007) 1.68
Long-term impact of acyclovir suppressive therapy on genital and plasma HIV RNA in Tanzanian women: a randomized controlled trial. J Infect Dis (2010) 1.67
A prospective study of bloodstream infections as cause of fever in Malawi: clinical predictors and implications for management. Trop Med Int Health (2004) 1.67
Extraspousal partnerships in a community in rural Uganda with high HIV prevalence: a cross-sectional population-based study using linked spousal data. J Acquir Immune Defic Syndr (2011) 1.65
Neuraminidase inhibitor resistance in influenza: assessing the danger of its generation and spread. PLoS Comput Biol (2007) 1.64
The association between Mycoplasma genitalium and HIV-1 acquisition in African women. AIDS (2012) 1.64
Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery. J Infect Dis (2013) 1.63
Lay health worker led intervention for depressive and anxiety disorders in India: impact on clinical and disability outcomes over 12 months. Br J Psychiatry (2011) 1.61
Impact of suppressive herpes therapy on genital HIV-1 RNA among women taking antiretroviral therapy: a randomized controlled trial. AIDS (2006) 1.58
The critical vaccination fraction for heterogeneous epidemic models. Math Biosci (2003) 1.54
Assessing treatment-selection markers using a potential outcomes framework. Biometrics (2012) 1.54
The courage to learn from our failures: syphilis control in men who have sex with men. Sex Transm Dis (2007) 1.52
Searching for psychosis: INTREPID (1): systems for detecting untreated and first-episode cases of psychosis in diverse settings. Soc Psychiatry Psychiatr Epidemiol (2015) 1.50
Epidemiology of ocular surface squamous neoplasia in Africa. Trop Med Int Health (2013) 1.50
Cervicovaginal HIV-1 and herpes simplex virus type 2 shedding during genital ulcer disease episodes. AIDS (2007) 1.48
Validation of brief screening tools for depressive and alcohol use disorders among TB and HIV patients in primary care in Zambia. BMC Psychiatry (2011) 1.47
Strengthening the reporting of Genetic RIsk Prediction Studies (GRIPS): explanation and elaboration. J Clin Epidemiol (2011) 1.46
Missed opportunities: poor linkage into ongoing care for HIV-positive pregnant women in Mwanza, Tanzania. PLoS One (2012) 1.45
HIV and other sexually transmitted infections in a cohort of women involved in high-risk sexual behavior in Kampala, Uganda. Sex Transm Dis (2011) 1.45
Parasitic central nervous system infections in immunocompromised hosts: malaria, microsporidiosis, leishmaniasis, and African trypanosomiasis. Clin Infect Dis (2005) 1.44
The global transmission and control of influenza. PLoS One (2011) 1.43
Towards a quantitative understanding of the within-host dynamics of influenza A infections. J R Soc Interface (2009) 1.40
Prevalence and indicators of HIV and AIDS among adults admitted to medical and surgical wards in Blantyre, Malawi. Trans R Soc Trop Med Hyg (2003) 1.39
The role of coinfections in HIV epidemic trajectory and positive prevention: a systematic review and meta-analysis. AIDS (2011) 1.38
Male circumcision and penile cancer: a systematic review and meta-analysis. Cancer Causes Control (2011) 1.38
Subtype-specific transmission probabilities for human immunodeficiency virus type 1 among injecting drug users in Bangkok, Thailand. Am J Epidemiol (2002) 1.37
Association between the pharmacokinetics and in vivo therapeutic efficacy of sulfadoxine-pyrimethamine in Malawian children. Antimicrob Agents Chemother (2005) 1.35
Economic evaluation of a task-shifting intervention for common mental disorders in India. Bull World Health Organ (2012) 1.31
Planning for the control of pandemic influenza A (H1N1) in Los Angeles County and the United States. Am J Epidemiol (2011) 1.31
A Resampling-Based Test to Detect Person-To-Person Transmission of Infectious Disease. Ann Appl Stat (2007) 1.30